InsiderTrades

Form 4 for IKT Inhibikase Therapeutics, Inc.

Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-17 · accession 0001104659-21-141628 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2021-11-19 2021-11-17 IKT Werner Milton H. Pres, CEO, Dir, 10% P - Purchase $1.97 +23.6K 23.6K New +$46.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-17 P A 3,186 $1.96 23,589 I Domestic Partner — — (F1) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
2 Common Common Stock 2021-11-17 P A 400 $1.93 23,589 I Domestic Partner — — (F1) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
3 Common Common Stock 2021-11-17 P A 1,334 $1.94 23,589 I Domestic Partner — — (F1) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
4 Common Common Stock 2021-11-17 P A 17,569 $1.98 23,589 I Domestic Partner — — (F1) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
5 Common Common Stock 2021-11-17 P A 1,100 $1.97 23,589 I Domestic Partner — — (F1) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.